New minimally invasive technique for treating corneal perforation
A Novel Sandwich Technique of Minimally Invasive Keratoplasty for Corneal Perforation
This study is testing a new, less invasive eye surgery technique to help people with corneal perforations heal better and improve their vision.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Sex | All |
| Sponsor | Tianjin Eye Hospital Academic / other |
| Locations | 1 site (Tianjin, Tianjin) |
| Trial ID | NCT06233409 on ClinicalTrials.gov |
What this trial studies
This study aims to describe a novel sandwich technique of minimally invasive keratoplasty (STMIK) using lenticules extracted from SMILE surgery to treat corneal perforations. It focuses on restoring the integrity of the eyeball quickly, reducing complications, and improving vision in cases where corneal material is limited. Participants will provide informed consent to undergo this new treatment method, which may yield positive outcomes despite some risks of complications.
Who should consider this trial
Good fit: Ideal candidates are patients with corneal perforations measuring 3mm or less who are willing to undergo this new treatment.
Not a fit: Patients with corneal perforations larger than 3mm or those unwilling to participate in the new technique may not benefit from this study.
Why it matters
Potential benefit: If successful, this technique could provide a new, effective treatment option for patients with corneal perforations.
How similar studies have performed: While this approach is innovative, it builds on existing techniques in corneal surgery, and similar studies have shown promise in utilizing lenticules for corneal repair.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with corneal perforation who are willing to undergo treatment with this new technique; 2. The size of cornea perforation was ≦ 3mm Exclusion Criteria: 1. The size of cornea perforation was \>3mm 2. Patients with corneal perforation who were unwilling to be treated with this new technique. 3. Patients who could not be followed up regularly.
Where this trial is running
Tianjin, Tianjin
- Tianjin Eye Hospital — Tianjin, Tianjin, China (Recruiting)
Study contacts
- Study coordinator: Luxia Chen，PHD,MD, Doctorate
- Email: Chen2006317@126.com
- Phone: Telephone: 022-27313336
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.